The RIQAS CYFRA 21-1 EQA programme is designed to cover the analysis of CYFRA 21-1 in clinical laboratories when monitoring the response to treatment of cancers such as non-small cell lung carcinoma, cervical, breast and bladder cancer.
Lyophilised samples
Monthly reporting
Testing covers the full range of clinically relevant decision levels
Submit results and view reports online via RIQAS.net
Randox Laboratories are providing the tools required to combat and detect COVID-19. We have solutions available for laboratory testing and consumer/company testing.
See the tools that Randox have to help diagnose and combat the virus.
Use the buttons below to direct you to the required pages.